An observational study in Psychiatric Disorder, Depression and Anxiety Disorders, sponsored by Karolinska Institutet. Recruiting at 1 site in Sweden. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-10-07.
Sponsored by Karolinska Institutet · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Many psychiatric patients are not sufficiently improved by current interventions. Functional magnetic imaging brain imaging (fMRI) has proven to be a promising method for predicting treatment outcomes in psychiatric treatment. Individuals moment-to-moment variability have not yet been evaluated as a predictor of treatment of three common forms of mental illness: depression, insomnia and health anxiety. The goal is to investigate whether objective measurements of brain function contribute to a better prediction of a patient's success in treatment than experiences and self-reports, e.g., treatment credibility and patients expectations about the treatment. The prediction model will be tested on internet-delivered CBT (iCBT) for depression, insomnia and social anxiety. Patients in each diagnostic group are asked for participation before treatment. The total number of participants in this study will amount to 225 participants. The goal is that 35% consists of healthy controls and that the remaining part is equally distributed between the three diagnostic patient groups.
Being able to better predict how well a psychiatric treatment will work for an individual has great value from both an economic and a treatment perspective. The findings from this study may contribute to increased knowledge about neurobiological complications in mental illness. In the longer term, it can lead to improved routines and help in clinical decision-making when patients should be recommended treatment.
Background: There is extensive evidence that cognitive behavioral therapy (CBT) is an effective method of treating common psychiatric disorders such as depression, social anxiety and insomnia. However, access to CBT is very limited. Furthermore, evidence suggest that internet-delivered CBT (iCBT) is as effective as traditional CBT. However, many psychiatric patients are not sufficiently improved by current interventions. Functional brain imaging has proven to be a promising method for predicting treatment outcomes in psychiatric treatment. Calculations on brain signal variability based on the blood-oxygen-level-dependent, BOLD signal (BOLD-fMRI) is a relatively new technique, shown to accurately predict chronological age and cognitive performance. Preliminary data from the investigators' lab suggest that pre-treatment BOLD-fMRI variability is predictive of CBT outcome in patients with social anxiety disorder.
Objectives: The objective of the study is to investigate whether objective measurements of brain function, in comparison with subjective experiences and self-reports (e.g., rating on treatment credibility and patients expectations about the treatment), contribute to better prediction of treatment outcome. The prediction model will be tested on iCBT for three common forms of mental disorders (depression, insomnia and social anxiety). Furthermore, participants will be compared with healthy controls to better understand neurobiological factors that may contribute to mental illness. Preliminary data from the investigators' lab suggest that BOLD-fMRI variability differs between social anxiety disorder participants and healthy individuals.
Method: A sample of outpatients scheduled for iCBT treatment for depression, insomnia or social anxiety at the Internet Psychiatry Unit at Karolinska University Hospital in Huddinge, Stockholm, will be invited to participate in the study. In addition to clinical participants, a healthy control group will be recruited via advertisement in social media. The length of the iCBT intervention is 12 weeks, during which participants engage in web-based treatment modules in a sequential manner, guided though a digital messaging system by a licensed psychologist who provides support and feedback on progress and assignments.
Measuring instruments: Brain imaging is performed before the patients initiate psychiatric treatment. The brain will be examined with structural and functional magnetic resonance imaging (MRI) using an EPI sequence to capture the BOLD signal (Philips 3-Tesla, 32 channel head-coil).
During the online self-referral process and during clinical intake interview, data on a number of potential predictor variables are collected:
Measurements only administered at screening/pre-treatment:
Behavioural measurements before/while undergoing MRI (all participants):
Predictors of treatment outcome
Behavioral predictor(s) of treatment outcome:
Brain-signal variability predictor(s), as derived from the following BOLD-fMRI experiments (all participants):
1,746 studies on the registry are indexed under Mental Disorders; 350 are open to participants now.
This study's planned enrollment of 150 is below the median of 220 across 391 observational studies indexed under Mental Disorders.
Browse Mental Disorders studies →Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 276 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Reported in previous studies from the clinic:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
DSM diagnostic criteria
The American Psychiatric Association’s manual of mental health diagnoses. DSM-5 (2013, revised as DSM-5-TR in 2022) replaced DSM-IV, and some studies still name the older edition. “Meets DSM criteria for …” means diagnosed by that edition’s diagnostic criteria, usually by a clinician in an interview.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
12 weeks of guided internet-delivered CBT for depression.
Behavioral: Internet-delivered cognitive behavioral therapy for major depressive disorder
12 weeks of guided internet-delivered CBT for insomnia.
Behavioral: Internet-delivered cognitive behavioral therapy for insomnia
12 weeks of guided internet-delivered CBT for social anxiety.
Behavioral: Internet-delivered cognitive behavioral therapy for social anxiety disorder
Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Cognitive behavioral therapy delivered over a period of 12 weeks, guided by a psychologist who provides written feedback on home assignments and questions.
Change from Baseline Patient Health Questionnaire 9 - Self Assessment (PHQ-9) to Post-treatment
The questionnaire has nine items. Overall score ranges from 0 to 27. Lower scores indicates a better outcome.
Time frame: Up to 6 months
Change from Baseline Insomnia Severity Index - Self Assessment (ISI) to Post-treatment
The questionnaire has seven items. The overall score ranges from 0 to 28. Lower scores indicates a better outcome.
Time frame: Up to 6 months
Change from Baseline Liebowitz Social Anxiety Scale - Self Assessment (LSAS-SR) to Post-treatment
The questionnaire has 48 items. The overall score ranges from 0 to 144. Lower scores indicates a better outcome.
Time frame: Up to 6 months
Consultation Satisfaction Questionnaire (CSQ-8) to Post-treatment
The questionnaire has 8 items. The overall score ranges from 8 to 32. Higher scores indicate a better outcome.
Time frame: 3 months
Social Phobia Inventory - Self Assessment (SPIN) 17 items. Overall score 0-68.
Self Assessment, 17 items. Overall score 0-68. Lower scores indicates a better outcome.
Time frame: Up to 6 months
World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0)
Self Assessment, 12 items. Overall score 0-100%. Lower scores indicate a better outcome.
Time frame: Up to 6 months
Change from Baseline Generalized Anxiety Disorder Scale (GAD-7) to Post-treatment
The questionnaire has seven items. The overall score ranges from 0 to 21. Lower scores indicate a better outcome.
Time frame: Up to 6 months
Montgomery Åsberg Depression Rating Scale - Self Assessment (MADRS-S)
Self Assessment, 9 items. Overall score 0-54. Lower scores indicate a better outcome.
Time frame: Up to 6 months
Started Apr 2022 (actual). Primary completion is estimated for Jan 2026, 45 months after the start.
Of 150 non-industry observational studies under Mental Disorders, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 77. This study's planned 45 months is above that.
Counting every sponsor, half of 157 studies reached it within 37 months; a quarter within 13 and three quarters within 77.
Mental Disorders covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.